Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Share NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease

Sign up to save your podcasts

NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease

NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease

More shows like NEJM Interviews

JAMA Editors' Summary

Medicine and Science from The BMJ

NEJM Journal Watch Podcasts: Clinical Conversations

NEJM This Week

JACC This Week

JAMA Clinical Reviews

Mayo Clinic Talks

JAMA Medical News

Eagle's Eye View: Your Weekly CV Update From ACC.org

Leadership Conversations

Core IM | Internal Medicine Podcast

Curbside Consults

Annals On Call Podcast

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

The Curious Clinicians

Infectious Disease Puscast

NEJM AI Grand Rounds

Intention to Treat

Not Otherwise Specified